NovaBridge Biosciences (FRA:0VY) Net Margin %: 0.00% (As of Dec. 2025)


FRA:0VY NovaBridge Biosciences FRA:0VY
30 GF Score
Price €1.38
! 2 Warning Signs
View Full Analysis

What is NovaBridge Biosciences Net Margin %?

NovaBridge Biosciences FRA:0VY -1.43% 30 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:0VY with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 945 Biotechnology companies, NovaBridge Biosciences ranks worse than 105820% on this metric.

Net margin is calculated as Net Income divided by its Revenue. NovaBridge Biosciences's Net Income for the three months ended in Dec. 2025 was €-26.29 Mil. NovaBridge Biosciences's Revenue for the three months ended in Dec. 2025 was €0.00 Mil. Therefore, NovaBridge Biosciences's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for NovaBridge Biosciences's Net Margin % or its related term are showing as below:


FRA:0VY's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.33
* Ranked among companies with meaningful Net Margin % only.

NovaBridge Biosciences  (FRA:0VY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

NovaBridge Biosciences Net Margin % Related Terms

NovaBridge Biosciences Net Margin % Historical Data

* Premium members only.

The historical data trend for NovaBridge Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovaBridge Biosciences Net Margin % Chart

NovaBridge Biosciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only -2,648.66 23,925.82 -32,842.59 0.00 0.00

NovaBridge Biosciences Quarterly Data
Sep19 Dec19 Jun20 Sep20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:0VY vs ELTX, CNTN, INDP: Net Margin % Comparison

For the Biotechnology subindustry, NovaBridge Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovaBridge Biosciences Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NovaBridge Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where NovaBridge Biosciences's Net Margin % falls into.


FRA:0VY
30GF Score
NovaBridge Biosciences FRA:0VY
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NovaBridge Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

NovaBridge Biosciences's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-39.514/0
= %

NovaBridge Biosciences's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-26.292/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
NovaBridge Biosciences (FRA:0VY) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on NovaBridge Biosciences and its competitors. According to the industry distribution chart, NovaBridge Biosciences ranks #999999 out of 945 companies in the Biotechnology industry.
Is NovaBridge Biosciences' Net Margin % too high?
NovaBridge Biosciences' current Net Margin % is 0.00%. Based on the distribution chart, NovaBridge Biosciences ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, NovaBridge Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does NovaBridge Biosciences' Net Margin % compare to ELTX and CNTN?
According to the Biotechnology industry distribution chart, NovaBridge Biosciences ranks #999999 out of 945 companies for Net Margin %. This places NovaBridge Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on NovaBridge Biosciences and its competitors. NovaBridge Biosciences's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovaBridge Biosciences stock overvalued right now?
NovaBridge Biosciences (FRA:0VY) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. NovaBridge Biosciences' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For NovaBridge Biosciences (FRA:0VY), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NovaBridge Biosciences Business Description

Other Exchanges NBP:USA
Address 2440 Research Boulevard, Suite 400, Rockville, MD, USA, 20850
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
30GF Score

Get the complete analysis for FRA:0VY

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.38
Price